Both studies only counted the number of moderate and severe exacerbations over the past one year that constitutes the definition of “exacerbator” [10]. A moderate exacerbation was defined as acute worsening of COPD symptoms that required outpatient treatment with corticosteroids and/or antibiotics;...
A COPD exacerbation, or flare-up, occurs when your COPD respiratory symptoms become much more severe. While everyone experiences exacerbations differently, there are a number of possiblewarning signs— and you may feel as if you can’t catch your breath. Exacerbations can last for days or even ...
PMCs, Mac-1, VWF and TG were positively associated with systemic inflammation (CRP). CLT was prolonged in AE-COPD patients with systemic inflammation. Moreover, platelet hyperreactivity on admission was associated with an increased risk for exacerbation relapse. Conclusions Acute exacerbations are ...
Risk factors of readmission to hospital cor a COPD exacerbation: a prospective study. for a COPD exacerbation and a wide range of modifiable potential risk factors, after adjusting for sociodemographic and clinical factors, has been assessed... Garcia-Aymerch,J.,Farrero,... - 《Thorax》 被引量...
aImagine me, how worried I am!!! 想象我,多么担心我是!!![translate] aAcute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study. 深刻恶化和呼吸传染在COPD (AERIS) : 协议为一项预期,观察上的一队人研究。[translate]...
Not all patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) benefit from treatment with systemic corticosteroids and antibiotics. The aim of the study was to identify criteria recommended in current COPD guidelines for treating acute exacerbations with systemic corticosteroids an...
This model can identify patients at high risk of acute exacerbation. Preventive measures and modification of treatment in these high-risk patients would improve survival. 展开 关键词: Chronic obstructive pulmonary disease (COPD) Risk factors Acute disease ...
There was not consistent evidence of heterogeneity of treatment effects for the outcomes by patient diagnosis (cancer vs no cancer; heart disease vs no heart disease; and lung disease vs no lung disease; eTables 4-6 in Supplement 2). Of these tests for interaction, only 1 statistically signif...
A total of 435 patients were referred for a COPD exacerbation warranting hospitalization; 107 patients were randomized to receive IV therapy, and 103 to receive oral therapy. Overall treatment failure within 90 days was similar, as follows: IV prednisolone, 61.7%; oral prednisolone, 56.3% (one-...
[defined as a progressive increase in ≥1 asthma symptoms or a decline in lung function for ≥2 consecutive days that does not meet the definition of severe asthma exacerbation), serious and nonserious adverse events, treatment-related adverse events, breakdown of adverse events, and all-cause ...